Industry Trend Analysis
The global DNA sequencing market is expected to be around 26 billion by 2025. The market is primarily driven by factors such as increasing demand for fast clinical diagnosis, increasing emphasis on cancer related research activities and collaborations between research institutions and pharmaceutical companies. Moreover, technological advancements in DNA sequencing are also expected to largely contribute the market growth over the forecast period. For instance, in September 2015, Oxford Nanopore Technologies developed MinION a DNA sequencer, which can be used in space. With the help of MinION it is possible to detect DNA sequence in humans with response to spaceflight and will help in the identification of DNA-based life somewhere in the universe. Such innovations will fuel the demand for DNA sequencing in coming years thus favorably contributing to the market growth. However, restraining factors such as dearth of trained professionals and high cost of DNA sequencing devices can hamper the market growth during the forecast period.
Request for Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54978
Product Outlook and Trend Analysis
In 2016, the consumables segment held a major share of the DNA sequencing market owing to their large scale adoption for sample preparation process and other activities in the entire DNA sequencing process. Different consumables such as sample preparation kits, disposables, reagent kits, accessories and sequencing kits are widely used for performing DNA sequencing processes by researchers.
Technology Outlook and Trend Analysis
The sequencing by synthesis segment held a significant share of the overall market in 2016. It is expected to dominate the global DNA sequencing market over the forecast period as the technology has large scale applications in sequencing protocols and is widely utilized in DNA sequencing platforms. This next generation sequencing technology delivers accurate data for a wide range of applications and reduces errors associated with strings of repeated homopolymers.
Applications Outlook and Trend Analysis
Biomarkers and cancer segment held a substantial share of the global DNA sequencing market in 2016 as DNA sequencing can generate potent biomarkers to be used for disease diagnostics. With the identification of variations in oncogenic DNA sequences in tumor tissues of patients suffering from cancer, effective cancer therapies can be developed. Somatic DNA sequence analysis enables biomarker discovery which can be used to better understand the tumor tissue.
Regional Outlook and Trend Analysis
North America dominated the global DNA sequencing market in 2016 owing to the availability of robust research and development infrastructure and increasing funding directed towards DNA related research activities in the U.S. Asia-Pacific DNA sequencing market is expected to register lucrative growth during the forecast period due to increasing awareness regarding applications of DNA sequencing and emphasis on improving research infrastructure in emerging countries such as China and India.
Make An Enquiry About this Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54978
The major players operating in the global DNA sequencing market emphasize on product development to introduce enhanced solutions for DNA sequencing applications and in turn acquire a major market share. For instance, in January 2017, Illumina, Inc., one of the leading providers of DNA sequencing technology, launched the NovaSeq series of DNA sequencer which has a scalable sequencing architecture. The platform enables high throughput sequencing with low per sample cost, ease of use and high flexibility. With the introduction of this new sequencer, Illumina intended to strengthen its competitive position in the global DNA sequencing market. Some of the key players operating in this market are, Pacific Biosciences of California, Inc., Integrated DNA Technologies, Inc., Hamilton Thorne, Inc., Abbott Laboratories Inc., Myriad Genetics, Inc., Agilent Technologies Inc., General Electric Company, ZS Genetics, Beckman Coulter, Inc. (a part of Danaher Corporation), Commonwealth Biotechnologies, Inc., Siemens AG, Bayer AG and LI-COR, Inc.
Technological advancements such as next-generation sequencing and chain terminator DNA sequencing are likely to propose significant growth opportunities for the key players in the global DNA sequencing market in coming years. With increased funding for R&D activities by pharmaceutical and biotechnology companies, the demand for DNA sequencing products and services is expected to increase considerably during the forecast period.
DNA Sequencing Market Segmentation:
Directly Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-CMR-HnM-54978/
Sequencing by Synthesis
Chain Termination Sequencing
Ion Semiconductor Sequencing
Single Molecule Real Time Sequencing
Sequencing by Ligation
Biomarkers and Cancer
By End User:
Hospitals & Clinics
Academic & Government Research Institutes
Rest of Europe
Rest of Asia-Pacific
Rest of the World
United Arab Emirates
Some of the key questions answered by the report are:
What was the market size in 2016 and forecast from 2017 to 2025?
What will be the industry market growth from 2017 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?